Zai Lab Limited (ZLAB) Surges 11.1%: Is This an Indication of Further Gains? [Yahoo! Finance]
Zai Lab Limited - American Depositary Shares (ZLAB)
US:NASDAQ Investor Relations:
zailaboratory.com/about/investors.php
Company Research
Source: Yahoo! Finance
The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 8.4% gain over the past four weeks. The recent surge in Zai Lab's stock price is likely due to positive investor expectations surrounding the strong ongoing performance of its marketed drugs, Zejula (for ovarian cancer), Vyvgart (for generalized myasthenia gravis), and Nuzyra (for infectious diseases). Additionally, the company has a robust pipeline of investigational drugs in development for various other oncology, infectious disease, neuroscience, and autoimmune conditions. This company is expected to post quarterly loss of $0.72 per share in its upcoming report, which represents a year-over-year change of -1.4%. Revenues are expected to be $105.19 million, up 51.9% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong cor
Show less
Read more
Impact Snapshot
Event Time:
ZLAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZLAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZLAB alerts
High impacting Zai Lab Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ZLAB
News
- Zai Lab's Growth Strategy And China's Policy Reforms Set Path For Profitability By 2025 [Seeking Alpha]Seeking Alpha
- Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024 [Yahoo! Finance]Yahoo! Finance
- Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024Business Wire
- Zai Lab Limited (ZLAB): Top ADR Stock According to Hedge Funds [Yahoo! Finance]Yahoo! Finance
- Zai Lab to Present Preliminary Data From Phase 1 Trial of ZL-1218, an Investigational Anti-CCR8 Antibody for the Treatment of Advanced Solid Tumors, at ESMO Congress 2024Business Wire
ZLAB
Earnings
- 8/6/24 - Miss
ZLAB
Sec Filings
- 9/26/24 - Form 144
- 9/19/24 - Form 144
- 9/5/24 - Form 4
- ZLAB's page on the SEC website